Doctor of U.S. President Joe Biden says he is fit for duty

EvanVucci/APBETHESDA,Md.—PresidentJoeBiden “continuestobefitforduty,”hisdoctorwroteWednesdayaftercon UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu




leisure time

author：explore    Page View：86152
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： 5 ways to address the shortage of health care workers
Next article： Cancer drug shortages should be causing more outrage